Skip to main content
OpenTrials
Completed

NCT Number: NCT03190720

Development of Exercise Promotion Program Using a Mobile Community

This study aims to investigate the effect of a mobile community based on a smart phone application to enhance physical activities of breast cancer survivors.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Asan Medical Center

Seoul, Korea, 05505, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stage 0-III breast cancer

Exclusion criteria

  • Stage IV breast cancer
  • Breast cancer recurrence or metastasis
  • Severe medical illness

Treatment and study plan

Mobile community

Device

A mobile community based on smartphone application (WalkOn) which gives participants to information about their own steps and others'.

Primary outcomes

  1. Distress

    Time frame: up to 3months

    Assessment using Patient Health Questionnaire (PHQ-9)

Secondary outcomes

  1. Physical activity

    Time frame: up to 3months

    Assessment using International Physical Activity Questionnaire (IPAQ)

Sponsors and collaborators

Lead sponsor

Asan Medical Center

Other

Registry information

Official study title

Development of Exercise Promotion Program Using a Mobile Community Based on a Smart Phone Application in Breast Cancer Survivors

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Jun 19, 2017
Registry last updated
Jan 10, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.